NTRA — Natera, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1604821 ·
Last close
$287.47
Market Cap
$41.68B
52W High
$437.41
52W Low
$181.00
ADV30
1,976,340
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 793,981,000 | 513,474,000 | -68,322,000 | -59,912,000 | 2,748,415,000 | 1,097,195,000 | 878,857,000 |
| Jun 2026 | 752,750,000 | 485,189,000 | -75,792,000 | -66,969,000 | 2,657,497,000 | 1,091,502,000 | 835,998,000 |
| Mar 2026 | 696,644,000 | 450,833,000 | -93,516,000 | -85,091,000 | 2,614,398,000 | 1,087,932,000 | 840,380,000 |
| Dec 2025 | 665,498,000 | 445,427,000 | -22,785,000 | 47,258,000 | 2,398,344,000 | 1,076,140,000 | 685,931,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$228,239,000
Investing CF
$-187,063,000
Financing CF
$50,305,000
CapEx
$-177,042,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.45
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-2,928,082,000
Inventory
$80,346,000
Receivables
$421,968,000
ST Investments
$0
EBIT TTM
$-248,883,000
Pretax Income TTM
$-252,701,000
Interest Exp TTM
$3,818,000
Analysts
22
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,908,875,008
EBITDA
$-175,816,992
Free Cash Flow
$84,539,376
Enterprise Value
$44,190,203,904
Total Cash
$1,097,195,008
Total Debt
$238,844,000
Shares Out
145,004,521
Trailing EPS
$-1.12
Book Value
$12.95
ROE
-10.6%
ROA
-6.8%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,306,113,000 | -309,911,000 | -208,160,000 | 2,398,344,000 | 685,931,000 | 1,712,413,000 | 215,301,000 |
| Dec 2024 | 1,696,911,000 | -222,294,000 | -190,426,000 | 1,660,735,000 | 465,315,000 | 1,195,420,000 | 135,664,000 |
| Dec 2023 | 1,082,571,000 | -446,245,000 | -434,801,000 | 1,441,699,000 | 676,372,000 | 765,327,000 | -246,955,000 |
| Dec 2022 | 820,222,000 | -541,040,000 | -547,799,000 | 1,394,474,000 | 688,730,000 | 705,744,000 | -431,501,000 |
TTM Snapshot
Revenues TTM
$2,707,077,000
NetIncome TTM
$-192,346,000
OpCashFlow TTM
—
Assets (Latest)
$2,657,497,000
Forward EPS
$-0.30
Max Pain — expiry 2026-12-18
max pain strike: $350.00 · spot: $289.50 · call oi: 7,366 · put oi: 2,397
Expected Move to 2026-12-18:
±$37.20
(12.85%) —
implied range
$252.30 –
$326.70
· ATM straddle on $290.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LH | LABCORP HOLDINGS INC. | $29.90B | $368.24 | — |
| DGX | QUEST DIAGNOSTICS INC | $28.29B | $256.35 | — |
| THC | TENET HEALTHCARE CORP | $22.45B | $282.07 | — |
| GH | Guardant Health, Inc. | $19.38B | $143.28 | — |
| HCA | HCA Healthcare, Inc. | $104.69B | $501.19 | — |
News headlines (Yahoo Finance, 1h cache)
What Explains Natera Stock's Nearly 10% Drop?
2026-11-18 23:48 · Yahoo
HLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening & Early Detection
2026-11-17 16:45 · Yahoo
Why Is Natera Stock Up Nearly 41% Since May?
2026-11-17 14:13 · Yahoo
Natera CFO Maps Multiple Paths to $6 Billion Revenue Target by 2029
2026-11-15 19:12 · Yahoo
Natera CFO Defends CEO Switch, Calls $6 Billion Revenue Target a “Way Station”
2026-11-14 09:12 · Yahoo
Is Natera (NTRA) Still Cheap, Or Is Cash Flow Doing The Heavy Lifting?
2026-11-13 12:11 · Yahoo
ETFs Are Net Sellers of Natera (NTRA) on Wednesday
2026-11-13 11:02 · Yahoo
How Incyte Trial And New Cancer Data Will Impact Natera Stock
2026-11-13 05:13 · Yahoo
Natera (NTRA) Following Clinical Momentum Looks Fully Valued To Some
2026-11-13 04:36 · Yahoo
Stanley Druckenmiller’s Next 13F Likely Lands Monday. 3 Positions to Watch
2026-11-12 14:53 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.